Cambridge’s T2 Biosystems, a developer of portable medical diagnostic products combining nanotechnology and miniaturized magnetic resonance imaging technology, today announced that John McDonough has been named its new CEO. McDonough, previously president of medical diagnostics and devices company Cytyc Development, will also join T2’s board of directors.

Bob is Xconomy's founder and chairman. You can email him at bbuderi@xconomy.com. Follow @bbuderi

• Share on Facebook
• Share on Twitter
• LinkedIn
• Email
• Reprints

Trending on Xconomy

• How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy
• Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson
• Redox Wrangles $33M to Become Healthcare’s Go-To Data Integrator